Search results
FDA approves bladder cancer treatment by Culver City company
LA Times via Yahoo News· 3 days agoThe Food and Drug Administration has approved Culver City-based ImmunityBio's treatment for bladder ...
ImmunityBio Inc. Drug Approved By FDA
The Post-Journal· 10 hours agoOn Monday, the Food and Drug Administration officially approved ANKTIVA, a treatment for unresponsive non-muscle invasive bladder cancer
FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer
Medical Xpress· 2 days agoChamie, who was the principal investigator for the trial, reported that this combination treatment...
FDA Approves New Bladder Cancer Drug
Medscape· 3 days agoThe first-in-class agent is approved alongside bacillus Calmette-Guérin to treat certain non–muscle-invasive bladder cancers that do not respond to...
Young breast cancer survivors almost twice as likely to develop another cancer, study finds
The Telegraph via Yahoo News· 11 hours agoParticular risks were found for lung, kidney, head and neck, bladder, esophageal and stomach cancers...
King Charles is receiving treatment for cancer — doctors explain what happens next
TODAY via Yahoo News· 7 days agoThe treatment was to be followed by a “short period of recuperation.” He entered London...Johns...
King Charles’ Funeral Plans Dusted Off, as His Health Remains a Mystery
The Daily Beast via Yahoo News· 6 hours agoPhoto Illustration by Luis G. Rendon/The Daily Beast/Getty ImagesIt’s the question everyone in...
U.S. FDA approves ImmunityBio's bladder cancer therapy
Reuters· 3 days ago, opens new tab combination therapy to treat a type of bladder cancer, marking an end to the...
ImmunityBio stock jumps as FDA clears bladder cancer therapy (NASDAQ:IBRX)
Seeking Alpha· 2 days agoShares of ImmunityBio (IBRX) surged 33% premarket after FDA clearance of its combination therapy for...
Recurrence Data for Narrow Band Imaging™ (NBI™) Technology Show Value in the Fight Against...
The Longview News-Journal· 1 day agoIndependent Meta-Analysis Shines Light on Important Visualization Modality